Clinical Trial: The Clinical Effects of an Advanced Modular Air
Cleaning Systems on
Allergic Asthma Sufferers?
A double-blind study performed over a period of 14 months by the
Charité Virchow Klinik, Berlin, and the Hedmark Hospitals Hamar,
Norway, investigated the clinical effects of modular air cleaning
systems on asthmatic children and adolescents sensitized to dog or
cat allergens.
Between September 1999 and December 2000, the Children’s
Hospital, Department of Pneumonology and Immunology of the Humboldt
University Berlin and the Children’s Hospital Hamar, district of
Hedmark, Norway, performed a long-term double-blind study
investigated the clinical effects of modular air cleaning systems on
asthmatic children and adolescents sensitized to dog or cat
allergens. The air cleaning systems used for the trial were
certified modular air cleaning systems IQAir Allergen 100
(Manufacturer: INCEN AG, Goldach, Switzerland).
The patients were children and adolescents aged 6 to 17 all
suffering from allergic asthma. 35 patients were from Berlin,
Germany and 54 patients from Hamar, Norway. In each of the 89
patients’ households, one air cleaning system was placed in the
living room and one in the patient's bedroom. The study was
completed in 81 cases. The patients were divided into 2 groups.
One group was treated with air cleaners containing active filters,
the other group received air cleaners with sham (placebo) filters.
In all patients, cortisone-steroid treatment was maintained during
the trial period in accordance with the Ethical Committee’s
recommendations.
Results:
• The air cleaners with active filters retained a significant
amount of airborne pet allergens. The filters were found to contain
very high concentrations (> 1000 µg per filter) of Fel d1 (cat
allergen) and Can f1 (dog allergen).
• In both Germany and Norway, there was a tendency to stabilization
of the asthma symptoms in patients using IQAir systems with active
filters.
• The group with the placebo filters, displayed a tendency to
increased bronchial hyper-responsiveness.
Comments on the results:
The results indicate that a stabilization of the allergic asthma
can be achieved with certified modular air cleaners. It is likely
that the beneficial effects of the air cleaners could be enhanced
further. It has been noted that many systems were not in constant
use during the trial period and that compliance varied between
different patients.
Air purification measures are recommended to be taken in
combination with regular ventilation and careful dust removal from
floors and furniture (source capture). While the active air cleaners
filtered large quantities of even the smallest of airborne
allergens, the heavier dust particles which quickly settle on
surfaces are best removed by source capture (e.g. wet mopping). In
how far such general hygiene measures were observed in the patients’
households was beyond the scope of this study. In individual cases
special rules for the keeping of pets may also have contributed to
the allergen-avoidance strategy and possibly enhanced the results
further. Keeping the complexity of this study in mind, it is not
clear whether the best possible coaching of the patients and parents
was performed with regard to these factors.
The possibility of a reduction, or even discontinuance of the
cortisone-treatment in response to the use of the air cleaning
system has to be looked at on a case by case basis. A reduction of
medication should only be considered if the importance of the
consequent and continuous use of the air cleaning system and strict
compliance with source control measures is understood and practiced
by the patient or parents.
Important data regarding the frequency and duration of use of the
active air cleaners by the patients was not systematically gathered
in the course of this trial. The findings, however, suggest that
there were major differences in how frequently and how long the air
cleaners were actually used by individual patients. Detailed data on
this subject would have helped to reveal (and disregard) cases where
no, or only little improvement in the allergic condition was due to
the lack of air cleaner usage.
In conclusion it can be noted that the use of certified modular
air cleaning systems can be an effective means for the control of
airborne cat and dog allergens. The study indicates that certified
modular air cleaning systems may help to stabilize the condition of
allergic asthmatics, i.e. help prevent a deterioration. How
effective an air cleaner is in individual cases may depend largely
on the frequency of use and general source control measures taken in
the patient's household.
Source:
Administration:Istituto San Blasius S.A.,Via Marconi 2,6900
Lugano,Switzerland Tel.+41 91 922 8463,Fax +41 91 922 8456
Informationsstelle für CH/D/A :St.Blasius Institut
AG,Postfach,9403 Goldach,Switzerland Tel.+41 71 844 0888,Fax +41 71
844 0889
E-mail:info@st-blasius.org
|